E Bartholomé

1.2k total citations
20 papers, 554 citations indexed

About

E Bartholomé is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology. According to data from OpenAlex, E Bartholomé has authored 20 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 6 papers in Immunology and 4 papers in Neurology. Recurrent topics in E Bartholomé's work include Multiple Sclerosis Research Studies (9 papers), Immunotherapy and Immune Responses (6 papers) and Peripheral Neuropathies and Disorders (2 papers). E Bartholomé is often cited by papers focused on Multiple Sclerosis Research Studies (9 papers), Immunotherapy and Immune Responses (6 papers) and Peripheral Neuropathies and Disorders (2 papers). E Bartholomé collaborates with scholars based in Belgium, United Kingdom and Switzerland. E Bartholomé's co-authors include Fabienne Willems, Michel Goldman, Kris Thielemans, Liliane Schandené, Alain Crusiaux, Richard Walker, Keith P. W. J. McAdam, Marianne A. B. van der Sande, Ousman Nyan and M. Dramaix and has published in prestigious journals such as Blood, Neurology and Stroke.

In The Last Decade

E Bartholomé

19 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Bartholomé Belgium 11 213 194 111 106 106 20 554
Anna N. Belova Russia 9 159 0.7× 184 0.9× 68 0.6× 99 0.9× 22 0.2× 51 453
Maria Antonietta Tommasi Italy 12 460 2.2× 93 0.5× 102 0.9× 106 1.0× 84 0.8× 14 634
Leszek Stawiarz Sweden 18 740 3.5× 122 0.6× 118 1.1× 274 2.6× 72 0.7× 35 1.0k
Shalom Haggiag Italy 17 376 1.8× 82 0.4× 131 1.2× 260 2.5× 38 0.4× 51 710
Andreas Lysandropoulos Belgium 11 360 1.7× 131 0.7× 159 1.4× 62 0.6× 51 0.5× 21 521
Mark Tullman United States 10 269 1.3× 62 0.3× 55 0.5× 89 0.8× 22 0.2× 16 401
Hans M. Schrijver Netherlands 15 276 1.3× 217 1.1× 124 1.1× 45 0.4× 32 0.3× 24 642
Damien Biotti France 15 287 1.3× 75 0.4× 55 0.5× 293 2.8× 51 0.5× 61 606
E. Mauch Germany 11 393 1.8× 69 0.4× 219 2.0× 251 2.4× 18 0.2× 27 603
Barbara Segal United States 14 113 0.5× 131 0.7× 102 0.9× 38 0.4× 34 0.3× 26 922

Countries citing papers authored by E Bartholomé

Since Specialization
Citations

This map shows the geographic impact of E Bartholomé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Bartholomé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Bartholomé more than expected).

Fields of papers citing papers by E Bartholomé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Bartholomé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Bartholomé. The network helps show where E Bartholomé may publish in the future.

Co-authorship network of co-authors of E Bartholomé

This figure shows the co-authorship network connecting the top 25 collaborators of E Bartholomé. A scholar is included among the top collaborators of E Bartholomé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Bartholomé. E Bartholomé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karatsidis, Angelos, Matthew Scaramozza, E Bartholomé, et al.. (2025). Characterizing gait in people with multiple sclerosis using digital data from smartphone sensors: A proposed framework. Multiple Sclerosis Journal. 31(5). 512–528. 1 indexed citations
2.
Scotland, Alf, Angelos Karatsidis, E Bartholomé, et al.. (2024). DISPEL: A Python Framework for Developing Measures From Digital Health Technologies. IEEE Open Journal of Engineering in Medicine and Biology. 5. 494–497.
3.
Scaramozza, Matthew, Patrizia A. Chiesa, Lauren Zajac, et al.. (2024). Konectom™ cognitive processing speed test enables reliable remote, unsupervised cognitive assessment in people with multiple sclerosis: Exploring the use of substitution time as a novel digital outcome measure. Multiple Sclerosis Journal. 30(9). 1193–1204. 4 indexed citations
4.
Decallonne, Brigitte, E Bartholomé, Valérie Delvaux, et al.. (2018). Thyroid disorders in alemtuzumab-treated multiple sclerosis patients: a Belgian consensus on diagnosis and management. Acta Neurologica Belgica. 118(2). 153–159. 28 indexed citations
5.
Bates, David & E Bartholomé. (2011). Treatment effect of natalizumab on relapse outcomes in multiple sclerosis patients despite ongoing MRI activity. Journal of Neurology Neurosurgery & Psychiatry. 83(1). 55–60. 13 indexed citations
6.
Airas, Laura, E Bartholomé, Nikolaos Grigoriadis, et al.. (2011). Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice. Therapeutic Advances in Neurological Disorders. 4(3). 139–168. 65 indexed citations
7.
Belachew, Shibeshih, Rémy Phan-Ba, E Bartholomé, et al.. (2010). Natalizumab induces a rapid improvement of disability status and ambulation after failure of previous therapy in relapsing‐remitting multiple sclerosis. European Journal of Neurology. 18(2). 240–245. 59 indexed citations
8.
Ravnborg, Mads, Per Soelberg Sørensen, Magnus Andersson, et al.. (2010). Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial. The Lancet Neurology. 9(7). 672–680. 58 indexed citations
9.
Ravnborg, Mads, Per Soelberg Sørensen, Mats Andersson, et al.. (2009). Monthly cycles of methylperdnisolone in combination with interferon beta-1a IM are efficacious in the treatment of early relapsing-remitting multiple sclerosis. The MECOMBIN study.. Multiple Sclerosis Journal. 15. 1 indexed citations
10.
Sande, Marianne A. B. van der, E Bartholomé, M. Dramaix, et al.. (2005). Stroke Presentation and Outcome in Developing Countries. Stroke. 36(7). 1388–1393. 101 indexed citations
11.
Beukinga, Ingrid, et al.. (2005). Cerebellar Hemorrhage due to Factor XI Deficiency. Cerebrovascular Diseases. 19(2). 138–139. 5 indexed citations
12.
Mavroudakis, Nicolas, et al.. (2003). Antiphospholipid antibodies and ischemic neuropathy following cardiac surgery.. PubMed. 103(3). 176–8. 3 indexed citations
13.
Buelens, Christel, E Bartholomé, Zoulikha Amraoui, et al.. (2002). Interleukin-3 and interferon β cooperate to induce differentiation of monocytes into dendritic cells with potent helper T-cell stimulatory properties. Blood. 99(3). 993–998. 69 indexed citations
14.
Paquier, Philippe, et al.. (2002). The cerebellum may be directly involved in cognitive functions. Neurology. 58(6). 967–970. 25 indexed citations
15.
Bartholomé, E, Ilse Van Aelst, Róbert Kiss, et al.. (2001). Human Monocyte-Derived Dendritic Cells Produce Bioactive Gelatinase B: Inhibition by IFN- β. Journal of Interferon & Cytokine Research. 21(7). 495–501. 47 indexed citations
16.
Toungouz, Michel, M. Lambermont, Thierry Velu, et al.. (2001). L’immunothérapie anti-tumorale à base de cellules dendritiques. Journal de la Société de Biologie. 195(1). 19–23. 1 indexed citations
17.
Toungouz, Michel, M. Lambermont, Thierry Velu, et al.. (2001). [Anti-tumor immunotherapy based on dendritic cells].. PubMed. 195(1). 19–23. 2 indexed citations
18.
Bartholomé, E, Fabienne Willems, Alain Crusiaux, et al.. (1999). beta IFN- Interferes with the Differentiation of Dendritic Cells from Peripheral Blood Mononuclear Cells: Selective Inhibition of CD40-Dependent Interleukin-12 Secretion. Journal of Interferon & Cytokine Research. 19(5). 471–478. 43 indexed citations
19.
Bartholomé, E, et al.. (1999). Interferon-beta inhibits Th1 responses at the dendritic cell level. Relevance to multiple sclerosis.. PubMed. 99(1). 44–52. 26 indexed citations
20.
Bartholomé, E, Mario Manto, J Jacquy, & Jerzy Hildebrand. (1996). Analysis of ballistic movements in ataxic hemiparesis following a pontine stroke. Journal of the Neurological Sciences. 139(2). 238–241. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna N. Belova Breakdown of academic impact, for papers by Maria Antonietta Tommasi Breakdown of academic impact, for papers by Leszek Stawiarz Breakdown of academic impact, for papers by Shalom Haggiag Breakdown of academic impact, for papers by Andreas Lysandropoulos Breakdown of academic impact, for papers by Mark Tullman Breakdown of academic impact, for papers by Hans M. Schrijver Breakdown of academic impact, for papers by Damien Biotti Breakdown of academic impact, for papers by E. Mauch Breakdown of academic impact, for papers by Barbara Segal
Rankless by CCL
2026